DeNoble V J, Mele P C, Porter J H
Pharmacol Biochem Behav. 1985 Nov;23(5):759-63. doi: 10.1016/0091-3057(85)90068-1.
Rats provided with unlimited access to intravenous doses of ethanol (30, 60, 90, 180, and 360 mg/kg/infusion) failed to initiate and maintain lever pressing that resulted in ethanol delivery. When pentobarbital (0.5 mg/kg/infusion) was substituted for ethanol, lever pressing increased. There were three indications of the positive reinforcing effects of pentobarbital: (1) a greater number of lever presses occurred when pentobarbital was response-contingent than when saline was available; (2) a greater number of responses were made on the pentobarbital lever than on a control "activity" lever; and (3) systematic changes in lever pressing were a function of pentobarbital dose (0.125, 0.25, 0.5, 1.0, and 2.0 mg/kg/infusion). Sequential substitution of ethanol (30, 90, 360 mg/kg/infusion) for pentobarbital failed to maintain lever pressing. However, access to combinations of ethanol (1, 3, 10, 30, 60 mg/kg/infusion) and a nonreinforcing dose of pentobarbital (0.125 or 0.25 mg/kg/infusion) did maintain lever pressing. As the dose of ethanol increased, the daily number of infusions first increased then decreased. Following a history of self-administration of ethanol-pentobarbital combinations, a retest of ethanol alone (10 or 30 mg/kg/infusions) followed by pentobarbital alone (0.125 or 0.25 mg/kg/infusion) failed to maintain lever pressing.
给大鼠无限制静脉注射不同剂量的乙醇(30、60、90、180和360毫克/千克/次输注),它们未能启动并维持能获得乙醇的杠杆按压行为。当用戊巴比妥(0.5毫克/千克/次输注)替代乙醇时,杠杆按压行为增加。有三个迹象表明戊巴比妥具有正性强化作用:(1)与可获得生理盐水时相比,当戊巴比妥的给予取决于反应时,杠杆按压次数更多;(2)在戊巴比妥杠杆上的反应次数比在对照“活动”杠杆上更多;(3)杠杆按压的系统性变化是戊巴比妥剂量(0.125、0.25、0.5、1.0和2.0毫克/千克/次输注)的函数。依次用乙醇(30、90、360毫克/千克/次输注)替代戊巴比妥未能维持杠杆按压。然而,给予乙醇(1、3、10、30、60毫克/千克/次输注)与非强化剂量的戊巴比妥(0.125或0.25毫克/千克/次输注)的组合确实能维持杠杆按压。随着乙醇剂量增加,每日输注次数先增加后减少。在有乙醇 - 戊巴比妥组合自我给药史后,先单独重测乙醇(10或30毫克/千克/次输注),然后单独重测戊巴比妥(0.125或0.25毫克/千克/次输注),未能维持杠杆按压。